Stefanie Kies
Senior Director Intellectual Property,
Polpharma Biologics
Sessions
-
Co-Chair Opening Remarks & Introduction13-Oct-2026
-
Securing Robust Antibody IP Portfolios in Europe and the U.S: Enablement, Obviousness and Strategies for Maximising Protection Scope13-Oct-2026
-
Co-Chair Opening Remarks & Recap of Day 114-Oct-2026
-
Recap of Day 2 & Chairs Conclude The Event14-Oct-2026